Skip to main content

Find Clinical Trials

Home
Conditions
Hypercholesterolemia, Autosomal Dominant, 3

Clinical trial condition

Hypercholesterolemia, Autosomal Dominant, 3

Explore clinical trials studying Hypercholesterolemia, Autosomal Dominant, 3. Study availability and eligibility vary by location and protocol.

15 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Hypercholesterolemia, Autosomal Dominant, 3 trial results

Completed

Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins

NCT01859455

Conditions: Dyslipidemias, Hypercholesterolemia, Hypercholesterolemia, Autosomal Dominant, 3, +5 more
Locations: Novartis Investigative Site Fort Myers, Florida, United States

Novartis Investigative Site Miramar, Florida, United States

View Trial Details

Completed

The Effect of Resistance Training on Proprotein Subtilisin Convertase Kexin 9 Level After Coronary Bypass Surgery

NCT02674659

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +6 more
Locations: Not specified

View Trial Details

Completed

Alirocumab in Patients With Acute Myocardial Infarction

NCT02938949

Conditions: Cardiovascular Diseases, Dyslipidemias, Heart Diseases, +14 more
Locations: Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia

NCT01979601

Conditions: Dyslipidemias, Hypercholesterolemia, Hypercholesterolemia, Autosomal Dominant, 3, +4 more
Locations: Novartis Investigative Site Miami Gardens, Florida, United States

Novartis Investigative Site Fargo, North Dakota, United States

View Trial Details

Active, Not Recruiting

Genetic Testing and Motivational Counseling for FH

NCT04656028

Conditions: Adherence, Adherence, Medication, Adherence, Patient, +39 more
Locations: National Medical Research Centre for Therapy and Preventive Medicine of the Ministry of Health of Russia Moscow, Russia

View Trial Details